相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Aspirin, low molecular weight heparin, or both in preventing pregnancy complications in women with recurrent pregnancy loss and factor V Leiden mutation
Cihan Karadag et al.
JOURNAL OF MATERNAL-FETAL & NEONATAL MEDICINE (2020)
Low molecular weight heparin promotes transcription and release of placental growth factor from endothelial cells
Kelsey McLaughlin et al.
AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY (2020)
Early Prophylactic Enoxaparin for the Prevention of Preeclampsia and Intrauterine Growth Restriction: A Randomized Trial
Elisa Llurba et al.
FETAL DIAGNOSIS AND THERAPY (2020)
Prediction and prevention of small-for-gestational-age neonates: evidence from SPREE and ASPRE
M. Y. Tan et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2018)
Aspirin versus Placebo in Pregnancies at High Risk for Preterm Preeclampsia
Daniel L. Rolnik et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Enoxaparin for the prevention of preeclampsia and intrauterine growth restriction in women with a history: a randomized trial
Katie M. Groom et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis
Stephanie Roberge et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Antiplatelet therapy before or after 16 weeks' gestation for preventing preeclampsia: an individual participant data meta-analysis
Shireen Meher et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2017)
Low-molecular-weight heparin and aspirin in the prevention of recurrent early-onset pre-eclampsia in women with antiphospholipid antibodies: the FRUIT-RCT
Marion E. van Hoorn et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2016)
Low-molecular-weight heparin and recurrent placenta-mediated pregnancy complications: a meta-analysis of individual patient data from randomised controlled trials
Marc A. Rodger et al.
LANCET (2016)
Enoxaparin and Aspirin Compared With Aspirin Alone to Prevent Placenta-Mediated Pregnancy Complications A Randomized Controlled Trial
Bassam Haddad et al.
OBSTETRICS AND GYNECOLOGY (2016)
Adjusting enoxaparin dosage according to anti-FXa levels and pregnancy outcome in thrombophilic women A randomised controlled trial
Raed Salim et al.
THROMBOSIS AND HAEMOSTASIS (2016)
LMWH in the prevention of preeclampsia and fetal growth restriction in women without thrombophilia A systematic review and meta-analysis
Salvatore Andrea Mastrolia et al.
THROMBOSIS AND HAEMOSTASIS (2016)
Low-dose aspirin plus low-molecular-weight heparin for the prevention of pre-eclampsia: yes, no or maybe
A. Sotiriadis
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
Prevention of pre-eclampsia by low-molecular-weight heparin in addition to aspirin: a meta-analysis
S. Roberge et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2016)
Plea for routinely presenting prediction intervals in meta-analysis
Joanna IntHout et al.
BMJ OPEN (2016)
Why is placentation abnormal in preeclampsia?
Susan J. Fisher
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2015)
Low-Molecular-Weight Heparin for Women With Unexplained Recurrent Pregnancy Loss A Multicenter Trial With a Minimization Randomization Scheme
Ekkehard Schleussner et al.
ANNALS OF INTERNAL MEDICINE (2015)
Low molecular weight heparin therapy during pregnancy is associated with elevated circulatory levels of placental growth factor
Y. Yinon et al.
PLACENTA (2015)
Prediction of Recurrent Preeclampsia Using First-Trimester Uterine Artery Doppler
Suzanne Demers et al.
AMERICAN JOURNAL OF PERINATOLOGY (2014)
Meta-analysis of low-molecular-weight heparin to prevent recurrent placenta-mediated pregnancy complications
Marc A. Rodger et al.
BLOOD (2014)
Update on the Diagnosis and Classification of Fetal Growth Restriction and Proposal of a Stage-Based Management Protocol
Francesc Figueras et al.
FETAL DIAGNOSIS AND THERAPY (2014)
Is thrombophilia associated with placenta-mediated pregnancy complications? A prospective cohort study
M. A. Rodger et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2014)
Antepartum dalteparin versus no antepartum dalteparin for the prevention of pregnancy complications in pregnant women with thrombophilia (TIPPS): a multinational open-label randomised trial
Marc A. Rodger et al.
LANCET (2014)
Low-Molecular Weight Heparin Increases Circulating sFlt-1 Levels and Enhances Urinary Elimination
Henning Hagmann et al.
PLOS ONE (2014)
Combined Screening for Preeclampsia and Small for Gestational Age at 11-13 Weeks
Leona C. Y. Poon et al.
FETAL DIAGNOSIS AND THERAPY (2013)
The definition of severe and early-onset preeclampsia. Statements from the International Society for the Study of Hypertension in Pregnancy (ISSHP)
Andrea L. Tranquilli et al.
PREGNANCY HYPERTENSION-AN INTERNATIONAL JOURNAL OF WOMENS CARDIOVASCULAR HEALTH (2013)
Heparin in pregnant women with previous placenta-mediated pregnancy complications: a prospective, randomized, multicenter, controlled clinical trial
Ida Martinelli et al.
BLOOD (2012)
VTE, Thrombophilia, Antithrombotic Therapy, and Pregnancy Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines
Shannon M. Bates et al.
CHEST (2012)
Robust meta-analytic conclusions mandate the provision of prediction intervals in meta-analysis summaries
Petra L. Graham et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2012)
Low-molecular-weight heparin added to aspirin in the prevention of recurrent early-onset pre-eclampsia in women with inheritable thrombophilia: the FRUIT-RCT
J. I. P. De Vries et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Thrombophilias and adverse pregnancy outcomes: results from the Danish National Birth Cohort
J. A. Lykke et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2012)
Is heparin a placental anticoagulant in high-risk pregnancies?
John C. P. Kingdom et al.
BLOOD (2011)
GRADE guidelines: A new series of articles in the Journal of Clinical Epidemiology
Gordon H. Guyatt et al.
JOURNAL OF CLINICAL EPIDEMIOLOGY (2011)
Unfractionated heparin for second trimester placental insufficiency: a pilot randomized trial
J. C. P. Kingdom et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Heparin promotes soluble VEGF receptor expression in human placental villi to impair endothelial VEGF signaling
S. Drewlo et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2011)
Aspirin and Heparin Effect on Basal and Antiphospholipid Antibody Modulation of Trophoblast Function
Christina S. Han et al.
OBSTETRICS AND GYNECOLOGY (2011)
Placental and trophoblastic in vitro models to study preventive and therapeutic agents for preeclampsia
K. Orendi et al.
PLACENTA (2011)
Addition of enoxaparin to aspirin for the secondary prevention of placental vascular complications in women with severe pre-eclampsia The pilot randomised controlled NOH-PE trial
Jean-Christophe Gris et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Thromboprophylaxis for recurrent miscarriage in women with or without thrombophilia HABENOX: A randomised multicentre trial
Jantien Visser et al.
THROMBOSIS AND HAEMOSTASIS (2011)
Interpretation of random effects meta-analyses
Richard D. Riley et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
The Cochrane Collaboration's tool for assessing risk of bias in randomised trials
Julian P. T. Higgins et al.
BMJ-BRITISH MEDICAL JOURNAL (2011)
Aspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage
Stef P. Kaandorp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Prevention of Preeclampsia and Intrauterine Growth Restriction With Aspirin Started in Early Pregnancy A Meta-Analysis
Emmanuel Bujold et al.
OBSTETRICS AND GYNECOLOGY (2010)
Enoxaparin for the secondary prevention of placental vascular complications in women with abruptio placentae The pilot randomised controlled NOH-AP trial
Jean-Christophe Gris et al.
THROMBOSIS AND HAEMOSTASIS (2010)
The recurrence risk of severe de novo pre-eclampsia in singleton pregnancies: a population-based cohort
S. D. McDonald et al.
BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2009)
Dalteparin for the prevention of recurrence of placental-mediated complications of pregnancy in women without thrombophilia: a pilot randomized controlled trial
E. Rey et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2009)
Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement
David Moher et al.
PLOS MEDICINE (2009)
Low-molecular weight heparin in patients with recurrent early miscarriages of unknown aetiology
A. M. Badawy et al.
JOURNAL OF OBSTETRICS AND GYNAECOLOGY (2008)
GRADE:: an emerging consensus on rating quality of evidence and strength of recommendations
Gordon H. Guyatt et al.
BRITISH MEDICAL JOURNAL (2008)
Antiplatelet agents for prevention of pre-eclampsia: a meta-analysis of individual patient data
Lisa M. Askie et al.
LANCET (2007)
Enoxaparin reduces H2O2-induced activation of human endothelial cells by a mechanism involving cell adhesion molecules and nuclear transcription factors
Ileana Manduteanu et al.
PHARMACOLOGY (2007)
Low-molecular-weight heparin improves the performance of uterine artery Doppler velocimetry to predict preeclampsia and small-for-gestational age infant in women with gestational hypertension
Michela Torricelli et al.
ULTRASOUND IN MEDICINE AND BIOLOGY (2006)
Low-molecular-weight heparin lowers the recurrence rate of preeclampsia and restores the physiological vascular changes in angiotensin-converting enzyme DD women
G Mello et al.
HYPERTENSION (2005)
Heparin and aspirin attenuate placental apoptosis in vitro: Implications for early pregnancy failure
P Bose et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Effects of low-molecular-weight and unfractionated heparin on trophoblast function
S Quenby et al.
OBSTETRICS AND GYNECOLOGY (2004)
Preventing adverse obstetric outcomes in women with genetic thrombophilia
E Grandone et al.
FERTILITY AND STERILITY (2002)
分享论文
